AHLA

Skip to Main Content

April 1, 2022

Health Law Weekly

Featured Articles

Antitrust Division Wins First Round in No-Poach Case, but There Is Lots More to Watch

Conversations with AHLA Leaders: Lisa Ohrin Wilson, Senior Technical Advisor, Centers for Medicare & Medicaid Services

Overcoming HIPAA Compliance and Cybersecurity Challenges for Digital Health Companies

Current Topics

Fraud and Compliance

Ambulance Company Pays $600K to Settle Improper Billing Allegations

Fifth Circuit Upholds Sentences, Convictions of Hospice Owner, CEO for “Pervasive” Fraud Scheme

Former President of Mail-Order Pharmacy Pleads Guilty in $35 Million Compounded Medication Scheme

Medical Practice Pays $286,000 to Resolve Improper Billing Claims

New York Home Health Agencies Reach $5.4 Million Medicaid Fraud Settlements

Pennsylvania Man Pleads Guilty to Defrauding Medicare, Improperly Receiving COVID-19 Financial Aid

Government Reimbursement

CMS Announces $110 Million to Expand Access to Home and Community-Based Services

CMS Proposes Medicare Payment Bump for IRFs in FY 2023

CMS Proposes Medicare Payment Increase of $50 Million to Psychiatric Facilities in FY 2023

Proposed Rule Would Increase Medicare Payments to Hospices by $580 Million in FY 2023

Supreme Court Declines Review of Decision Rejecting States’ Challenge to ACA Insurer Provider Fee

U.S. Court in DC Upholds PRRB Jurisdictional Dismissal of Hospitals’ DSH Challenge

Health Care Finance and Transactions

UnitedHealth to Acquire Home Health Provider LHC Group for $5.4 Million

Health Information

OCR Resolves Four HIPAA Enforcement Actions Involving Right of Access, Improper Disclosures

Health Policy and Administration

Biden Administration’s FY 2023 Budget Seeks “Historic” Funding for Future Pandemic Preparedness

National Health Spending Growth Slows to 4.2% in 2021 as Federal Outlays for COVID Decline

Life Sciences

CVS, Teva, Allergan, to Pay Florida over $870 Million in Opioid-Related Settlement

House Clears Measure to Cap Out-of-Pocket Insulin Costs

HRSA Refers Boehringer Ingelheim to OIG Citing 340B Noncompliance

Current Issue

Health Law Weekly Issue - April 1, 2022